Orthopaedic Product News & Orthopaedic Press Releases | Orthogate Professionals

Here are five takeaways:

1. Asia is expected to witness a rapid growth due to an increasing population, rising awareness of technologies and increasing per capita income of hospitals.

2. The slowdown of the economies in European countries will also drive the Asian market.

3. Aging populations and government initiatives in numerous countries are driving this market globally.

4. Startup costs and complex machines are obstacles to the growth of the spine surgery devices market.

5. Alphatec Spine, DePuy Spine, Medtronic, Stryker, Smith & Nephew, Orthovita and Zimmer Spine lead the market.

More articles on devices:

Over the past several years I have been commenting about the incredible number of metal on metal hip implant replacement failures. The epidemic of premature metal on metal hip implant failure continues surge at an alarming rate. According to experts, all metal on metal hips will eventually fail prematurely, it is not a question of if but when.

Hip replacement surgery (hip arthroplasty) has helped millions of people overcome painful degenerative arthritis, hip fractures and improve their mobility. Unfortunately, hip metal implants are not risk free or without side effect complications. Many hip implant patients have suffered premature implant failure and other serious complications associated with their hip replacement.

French orthopedic implant company Implanet said Wednesday it won expanded FDA 510(k) clearance for its Jazz spinal implant allowing it to be used with other posterior thoraco-lumbar fixation systems.

The Jazz implant is intended to provide temporary stabilization as a bone anchor during bone fusions and to aid in the repair of bone fractures.  The device is cleared for spinal trauma surgeries, spinal reconstructive surgeries and spinal degenerative surgeries, according to its website.

“We had been eagerly awaiting this latest clearance, which represents a major milestone in our development. Surgeons may now utilize their posterior fixation system of choice when incorporating Jazz into their hybrid constructs.

Here are five things to know:

1. The company will present its two new ViewSite TC model devices.

2. The devices were designed much smaller in size to adapt to surgeons needs to perform less invasive surgery while still using endoscopes.

3. The smallness also allows surgeons to perform minimally invasive surgery in areas where existing retractors prove too invasive.

4. Vycor plans to put the devices on the market in the fourth quarter of 2015.

5. The company will also present its prototype of a set of four VBAS devices intended to be used with Image Guided Systems.

• Exclusive Unyvero distribution agreement with Beijing Clear Biotech Co., Ltd. for Mainland China, Hong Kong and Taiwan
• Clinical trials for CFDA regulatory approval in preparation

HOLZGERLINGEN, Germany, Sept. 25, 2015 (GLOBE NEWSWIRE) -- Curetis AG, a developer of next-level molecular diagnostic solutions, today announced that it has signed an exclusive distribution agreement (the "Agreement") for China, Hong Kong and Taiwan (collectively "Greater China") with Beijing Clear Biotech Co. Ltd. The Agreement, effective from September 25, 2015, comprises the Unyvero Systems and P55 and i60 ITI Application Cartridges. Based in Beijing and founded in 2001, Beijing Clear Biotech is an experienced and prominent distributor of prime medical technology brands throughout Greater China.

Nexxt Spine, LLC, a medical device company focused on designing, manufacturing and distributing innovative spinal solutions to meet the evolving needs of surgeons and health care institutions, today announced recent additions to the company’s strategic sales personnel to strengthen sales and further position the company for long term growth. Bill Del Russo was appointed to Vice President of Sales, George Sims was named as the Central Sales Director and Mark Medina as the Western Sales Director.

“As part of our recent growth, we’re moving very quickly to put experienced team members in key roles across sales and business development to ensure we continue providing the most effective and innovative spine programs for our growing surgeon base,” said Andy Elsbury, President of Nexxt Spine.